Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-11-17 Sale | 2021-11-19 3:34 pm | Trillium Therapeutics Inc. | TRIL | Walker Paul Edward Director | 5,736,363 | $0 | $0 | 0 (Indirect Direct) | View |
| 2021-11-17 Sale | 2021-11-19 1:30 pm | Trillium Therapeutics Inc. | TRIL | Harrison Rosemary See Remarks | 75 | $0 | $0 | 0 (Direct) | View |
| 2021-07-07 Sale | 2021-07-09 4:30 pm | Trillium Therapeutics Inc. | TRIL | Uger Robert Chief Scientific Officer | 3,646 | $9 | $32,814 | 102,083 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2021-07-07 Exercise | 2021-07-09 4:30 pm | N/A 2029-11-07 | Trillium Therapeutics Inc. | TRIL | Uger Robert Chief Scientific Officer | 3,646 | $0 | 102,083 (Direct) | View |
| 2021-07-07 Exercise | 2021-07-09 4:30 pm | N/A N/A | Trillium Therapeutics Inc. | TRIL | Uger Robert Chief Scientific Officer | 3,646 | $0.3039 | 102,083 (Direct) | View |
| 2021-07-01 Option Award | 2021-07-02 4:35 pm | N/A 2031-07-01 | Trillium Therapeutics Inc. | TRIL | MACKEY CATHERINE J Director | 67,000 | $0 | 67,000 (Direct) | View |